Demirdogen, B. C. Et Al. 2008. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke. CLINICAL BIOCHEMISTRY , vol.41 , 1-9.

Demirdogen, B. C., Turkanoglu, A., Bek, S., Sanisoglu, Y., Demirkaya, S., Vural, O., ... Arinc, E.(2008). Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke. CLINICAL BIOCHEMISTRY , vol.41, 1-9.

Demirdogen, Birsen Et Al. "Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke," CLINICAL BIOCHEMISTRY , vol.41, 1-9, 2008

Demirdogen, Birsen C. Et Al. "Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke." CLINICAL BIOCHEMISTRY , vol.41, pp.1-9, 2008

Demirdogen, B. C. Et Al. (2008) . "Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke." CLINICAL BIOCHEMISTRY , vol.41, pp.1-9.

@article{article, author={Birsen Can Demirdogen Et Al. }, title={Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke}, journal={CLINICAL BIOCHEMISTRY}, year=2008, pages={1-9} }